Full Text View
Tabular View
No Study Results Posted
Related Studies
Bupropion SR for Treating Smokeless Tobacco Use
This study has been completed.
Study NCT00414180   Information provided by Mayo Clinic
First Received: December 20, 2006   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Smokeless Tobacco
Interventions listed in this trial
Bupropion SR
Additional drug interventions recognized in this trial
Bupropion
Lobeline
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Autonomic Agents
Central Nervous System Agents
Cholinergic Agents
Cholinergic Agonists
Dopamine Agents
Dopamine Uptake Inhibitors
Ganglionic Stimulants
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Nicotinic Agonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
Mayo Clinic
West Virginia University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services